-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Immune Disorders Sessions

Friday, December 6, 2024

top

11:00 AM-2:00 PM


A Violent Graft in a Vulnerable Host: The Future of aGVHD Management  
Friday Satellite Symposia

Saturday, December 7, 2024

top

8:00 AM-9:00 AM


Nonmalignant Hematologic Disorders Forum: Deeper Dive Into PNH, aHUS, and ITP  
Industry Forums

9:00 AM-7:30 PM


Poster Session I - Viewing  
Events

9:30 AM-10:45 AM


ALPS, CVID, and LGL: When Autoimmune Cytopenias Are a Marker of Underlying Immune Disease  
Education Program


Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation  
Education Program

9:30 AM-11:00 AM


722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Predicting and Treating Acute and Chronic GVHD  
Oral and Poster Abstracts


803. Emerging Tools, Techniques, and Artificial Intelligence in Hematology: New Approaches to Predicting Patient Outcomes in Hematologic Malignancies  
Oral and Poster Abstracts

11:15 AM-12:15 PM


Career Development Lunch
Trainee Activities and Services

12:00 PM-1:30 PM


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Know Thy(mus) Self, Know Thy Enemy: From Lymphocyte Genetic Variation to Disease  
Oral and Poster Abstracts


331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: A Brave New World: Novel Tools, Targets and Treatments in TTP  
Oral and Poster Abstracts


711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Innovations in Mobilization, Collection, and Manufacturing for Cellular Therapies  
Oral and Poster Abstracts

2:00 PM-3:30 PM


101. Red Cells and Erythropoiesis, Excluding Iron: Effects of Inflammation on Erythropoiesis and the Niche  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Mechanisms of Hematopoietic Aging and Inflammation  
Oral and Poster Abstracts


701. Experimental Transplantation: Basic and Translational: GVHD, Mucosal Immunology and the Microbiome  
Oral and Poster Abstracts

4:00 PM-5:15 PM


HIT-and-Run: Challenges in Diagnosis and Management of Heparin-Induced Thrombocytopenia  
Education Program

4:00 PM-5:30 PM


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Optimizing Outcomes in Pediatric, Adolescent and Young Adult Patients  
Oral and Poster Abstracts

5:30 PM-7:30 PM


Poster Session I - Presentations (for in-person participants)  
Events


114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


201. Granulocytes, Monocytes, and Macrophages: Poster I  
Oral and Poster Abstracts


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster I  
Oral and Poster Abstracts


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational: Poster I  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Poster I  
Oral and Poster Abstracts


622. Lymphomas: Translational - Non-Genetic: Poster I  
Oral and Poster Abstracts


625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster I  
Oral and Poster Abstracts


701. Experimental Transplantation: Basic and Translational: Poster I  
Oral and Poster Abstracts


704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster I  
Oral and Poster Abstracts


711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster I  
Oral and Poster Abstracts


722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster I  
Oral and Poster Abstracts


723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster I  
Oral and Poster Abstracts


801. Gene Therapies: Poster I  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I  
Oral and Poster Abstracts


909. Education, Communication, and Workforce: Poster I  
Oral and Poster Abstracts

Sunday, December 8, 2024

top

9:00 AM-8:00 PM


Poster Session II - Viewing  
Events

9:30 AM-11:00 AM


201. Granulocytes, Monocytes, and Macrophages: Uncovering Pathways Impacting Inflammation, Myeloid Proliferation and Severe Congenital Neutropenia  
Oral and Poster Abstracts


301. Platelets and Megakaryocytes: Basic and Translational: Megakarocyte and Platelet Biology: From Formation to Function  
Oral and Poster Abstracts

12:00 PM-1:30 PM


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Big Data and Basic Science  
Oral and Poster Abstracts

4:30 PM-6:00 PM


704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: B Cell-directed CAR T Cell Therapies for ALL and for Autoimmunity  
Oral and Poster Abstracts


907. Outcomes Research: Plasma Cell Disorders: Frailty, Supportive Care, and Factors Impacting Outcomes  
Oral and Poster Abstracts

6:00 PM-8:00 PM


Poster Session II - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster II  
Oral and Poster Abstracts


201. Granulocytes, Monocytes, and Macrophages: Poster II  
Oral and Poster Abstracts


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II  
Oral and Poster Abstracts


301. Platelets and Megakaryocytes: Basic and Translational: Poster II  
Oral and Poster Abstracts


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Poster II  
Oral and Poster Abstracts


508. Bone Marrow Failure: Acquired: Poster II  
Oral and Poster Abstracts


605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster II  
Oral and Poster Abstracts


621. Lymphomas: Translational – Molecular and Genetic: Poster II  
Oral and Poster Abstracts


622. Lymphomas: Translational - Non-Genetic: Poster II  
Oral and Poster Abstracts


634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


637. Myelodysplastic Syndromes: Clinical and Epidemiological: Poster II  
Oral and Poster Abstracts


701. Experimental Transplantation: Basic and Translational: Poster II  
Oral and Poster Abstracts


704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster II  
Oral and Poster Abstracts


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster II  
Oral and Poster Abstracts


722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster II  
Oral and Poster Abstracts


901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II  
Oral and Poster Abstracts

Monday, December 9, 2024

top

9:00 AM-8:00 PM


Poster Session III - Viewing  
Events

10:30 AM-12:00 PM


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Clinical Evidence in ITP  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Innovative Approaches to Improve Care for Understudied Non-Malignant Hematologic Diseases  
Oral and Poster Abstracts

2:45 PM-4:15 PM


201. Granulocytes, Monocytes, and Macrophages: From Inflammation to Hemophagocytic Lymphohistiocytosis  
Oral and Poster Abstracts

4:30 PM-6:00 PM


101. Red Cells and Erythropoiesis, Excluding Iron: Erythropoiesis in Disease  
Oral and Poster Abstracts


801. Gene Therapies: Gene Therapies for Hemophilia, Cancer and Immunodeficiencies  
Oral and Poster Abstracts

6:00 PM-8:00 PM


Poster Session III - Presentations (for in-person participants)  
Events


101. Red Cells and Erythropoiesis, Excluding Iron: Poster III  
Oral and Poster Abstracts


102. Iron Homeostasis and Biology: Poster III  
Oral and Poster Abstracts


201. Granulocytes, Monocytes, and Macrophages: Poster III  
Oral and Poster Abstracts


203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster III  
Oral and Poster Abstracts


311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


330. Vascular Biology, Thrombosis, and Thrombotic Microangiopathies: Basic and Translational: Poster III  
Oral and Poster Abstracts


503. Clonal Hematopoiesis, Aging, and Inflammation: Poster III  
Oral and Poster Abstracts


506. Bone Marrow Microenvironment: Poster III  
Oral and Poster Abstracts


509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster III  
Oral and Poster Abstracts


605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster III  
Oral and Poster Abstracts


642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Poster III  
Oral and Poster Abstracts


701. Experimental Transplantation: Basic and Translational: Poster III  
Oral and Poster Abstracts


702. CAR-T Cell Therapies: Basic and Translational: Poster III  
Oral and Poster Abstracts


703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster III  
Oral and Poster Abstracts


704. Cellular Immunotherapies: Early Phase Clinical Trials and Toxicities: Poster III  
Oral and Poster Abstracts


721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III  
Oral and Poster Abstracts


722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Poster III  
Oral and Poster Abstracts


723. Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence: Poster III  
Oral and Poster Abstracts


905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III  
Oral and Poster Abstracts